Healthcare Realty Trust is a real estate investment trust that integrates owning, managing, financing and developing income-producing real estate properties associated primarily with the delivery of outpatient healthcare services throughout the United States. As of September 30, 2020, the Company owned 211 real estate properties in 24 states totaling 15.5 million square feet and was valued at approximately $5.5 billion. The Company provided leasing and property management services to 11.9 million square feet nationwide.
Healthcare Realty Trust Stock Up 1.0 %
Shares of NYSE:HR traded up $0.27 during trading on Friday, reaching $26.34. 107,848 shares of the company traded hands, compared to its average volume of 12,857,392. The firm has a fifty day simple moving average of $26.01 and a 200 day simple moving average of $27.75. Healthcare Realty Trust has a 1-year low of $23.28 and a 1-year high of $34.83. The firm has a market cap of $6.03 billion, a P/E ratio of 89.90 and a beta of 0.67.
Healthcare Realty Trust Dividend Announcement
The company also recently announced a Variable dividend, which will be paid on Tuesday, August 30th. Shareholders of record on Monday, August 15th will be paid a $0.109 dividend. The ex-dividend date is Friday, August 12th. Healthcare Realty Trust's dividend payout ratio (DPR) is currently 458.64%.
Wall Street Analyst Weigh In
A number of equities research analysts have recently issued reports on HR shares. Berenberg Bank lowered Healthcare Realty Trust from a "buy" rating to a "hold" rating and cut their target price for the stock from $35.00 to $32.00 in a research report on Tuesday, May 10th. Sumitomo Mitsui Financial Group raised shares of Healthcare Realty Trust from a "neutral" rating to an "outperform" rating and set a $30.00 price objective for the company in a research note on Thursday. BMO Capital Markets started coverage on shares of Healthcare Realty Trust in a research report on Wednesday, June 22nd. They issued a "hold" rating and a $28.00 target price on the stock. Credit Suisse Group decreased their price objective on shares of Healthcare Realty Trust from $34.00 to $29.00 and set an "outperform" rating for the company in a research note on Monday, July 18th. Finally, Barclays assumed coverage on shares of Healthcare Realty Trust in a research note on Tuesday, April 26th. They set an "overweight" rating and a $33.00 target price on the stock. One research analyst has rated the stock with a sell rating, five have given a hold rating and four have assigned a buy rating to the company's stock. According to data from MarketBeat, Healthcare Realty Trust currently has a consensus rating of "Hold" and a consensus price target of $30.29.